mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.03 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.03 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.03 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.03 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.03 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.04 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.04 |